Amylyx is progressing promising treatments for Wolfram Syndrome and Progressive Supranuclear Palsy with potential phase 3 trials. Learn more on AMLX stock here.
Neuroscience research has increasingly focused on the role of autophagy in maintaining neuronal health and metabolism. Neurons, with their complex architecture and post-mitotic nature, require ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
By replicating a spaced learning process, scientists observed memory gene activation in these non-neural cells, expanding possibilities for enhancing learning and treating memory-related health issu..
Clene (NASDAQ: CLNN) reported its Q3 2024 financial results and provided updates on its CNM-Au8 programs. Key operational highlights included a recent FDA meeting to discuss the potential for ...